Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Leukemia 1Anemia, Aplastic 1Anemia 1

Interventions

fludarabine phosphate 13Cyclophosphamide 13fludarabine 10Whole-Body Irradiation 10Melphalan 10Tacrolimus 9Busulfan 9Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 7Alemtuzumab 5Cyclosporine 4Antilymphocyte Serum 4Stem Cell Transplantation 3Methotrexate 3Granulocyte Colony-Stimulating Factor 3thymoglobulin 2sargramostim 2Thiotepa 2Rituximab 2Methylprednisolone 2Filgrastim 2posaconazole 1methanesulfonic acid 1merphos 1ibrutinib 1Transplantation, Homologous 1Transplantation 1Surveys and Questionnaires 1Standard of Care 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia, Aplastic × Immunosuppression Therapy × Clear all
NCT00987480 2018-07-10

Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
45 enrolled 12 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡